Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis

NCT00005766 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Creatinine

Sponsor

National Center for Research Resources (NCRR)